在基因编码扩展治疗中使用非正规氨基酸:对小鼠肠道微生物群的影响
Manyu Liang1, Yanhong Yang1, Jing Zhang1
1Green Pharmaceutical Technology Key Laboratory of Luzhou, School of Pharmacy, Southwest Medical University, Luzhou, China.
Microbial biotechnology
|October 24, 2023
概括
4-乙-氨酸 (pAcF) 是一种更安全的非正规氨基酸 (ncAA) 用于遗传密码扩展疗法. 与pIoF和pMeoF相比,它在小鼠中引起的生理和肠道微生物群破坏较少.
科学领域:
- 生物化学和分子生物学
- 药理学和毒理学 药理学和毒理学
- 微生物学和免疫学
背景情况:
- 新兴的疫苗和细胞疗法利用遗传密码扩展.
- 非正规氨基酸 (ncAAs) 的口服是控制治疗性蛋白质水平和病原体生长的关键.
- 评估ncAAs的毒性对于开发基于基因编码扩展的安全有效疗法至关重要.
研究的目的:
- 评估三种常用的ncAAs的毒性:4-乙-氨 (pAcF),4--氨 (pIoF) 和4-甲基-氨 (pMeoF).
- 为了确定这些ncAAs在口服后对小鼠器官,血清生物化学和肠道微生物群的影响.
- 为基因编码扩展型疫苗和细胞疗法确定最适合的ncAAs.
主要方法:
- 对小鼠进行pAcF,pIoF和pMeoF的口服.
- 对主要器官的影响分析.
- 对血清生物化学参数的评估.
- 评估肠道微生物群组成的变化.
主要成果:
- pIoF和pMeoF显著改变了小鼠的血清生物化学参数.
- 与pAcF相比,口服pIoF和pMeoF导致肠道微生物组成的变化更大.
- 与pIoF和pMeoF相比,pAcF对生理和肠道微生态平衡的干扰最小.
结论:
- 由于其毒性较低,pAcF更适合用于基因编码扩展型疫苗和细胞疗法.
- pIoF和pMeoF具有更大的破坏生理和肠道微生态平衡的潜力.
- 这些发现指导了为更安全的治疗应用选择ncAAs.
相关概念视频
Microorganisms in Medicine and Therapeutics
35
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
35
Genome Size and the Evolution of New Genes
8.0K
While every living organism has a genome of some kind (be it RNA, or DNA), there is considerable variation in the sizes of these blueprints. One major factor that impacts genome size is whether the organism is prokaryotic or eukaryotic. In prokaryotes, the genome contains little to no non-coding sequence, such that genes are tightly clustered in groups or operons sequentially along the chromosome. Conversely, the genes in eukaryotes are punctuated by long stretches of non-coding sequence.
8.0K


